Free Case Evaluation
|
ReNu Timeline
May 2004—FDA gives approval to Bausch & Lomb’s contact lens solution ReNu with MoistureLoc.
Late 2004—ReNu with MoistureLoc goes on market.
Mid-2005—Opthalmologists in Hong Kong voice concern about number of patients suffering from Fusarium keratitis. Public there is alerted about four recent cases of Fusarium keratitis, but no connection to Bausch & Lomb’s ReNu with MoistureLoc is mentioned.
October 2005—Health officials in Hong Kong notify Bausch & Lomb of possible link between outbreak of Fusarium keratitis and ReNu with MoistureLoc. Bausch & Lomb does not inform FDA of this.
November 2005—Hong Kong health officials tell Bausch & Lomb about more contact lens wearers being hospitalized due to severe and debilitating Fusarium keratitis symptoms.
February 20, 2006—After 29 cases of Fusarium keratitis are found in Hong Kong, Singapore and Malaysia since November 2005, Bausch & Lomb suspends sales of ReNu there.
March 3, 2006—Dr. David Chu in New Jersey tells Bausch & Lomb about three cases of Fusarium keratitis since December. When company fails to notify CDC within five days, Dr. Chu does. U.S. investigation commences.
March 22, 2006—FDA begins intensive inspection of Bausch & Lomb’s plant in Greenville, South Carolina.
April 10, 2006—Bausch & Lomb stops shipping ReNu with MoistureLoc to stores in U.S. but says they may continue to sell existing product until supplies run out.
April 13, 2006—Bausch & Lomb issues U.S. ReNu recall. Walgreens, WalMart and CVS don’t wait and have already removed ReNu with MoistureLoc from their shelves. AOA concurs with this action.
April 17, 2006—First personal injury ReNu lawsuits are filed in New York and Miami.
May 15, 2006—Bausch & Lomb issues worldwide ReNu recall.
August 23, 2006— Journal of the American Medical Association publishes results of CDC’s investigation. It demonstrates link between outbreak of Fusarium keratitis with use of ReNu with MoistureLoc.
October 2006—FDA issues 11-page warning letter to Bausch & Lomb, citing systemic violations of federal regulations at Greenville plant.
The information on this page pertains only to ReNu with MoistureLoc and not all ReNu products.
Late 2004—ReNu with MoistureLoc goes on market.
Mid-2005—Opthalmologists in Hong Kong voice concern about number of patients suffering from Fusarium keratitis. Public there is alerted about four recent cases of Fusarium keratitis, but no connection to Bausch & Lomb’s ReNu with MoistureLoc is mentioned.
October 2005—Health officials in Hong Kong notify Bausch & Lomb of possible link between outbreak of Fusarium keratitis and ReNu with MoistureLoc. Bausch & Lomb does not inform FDA of this.
Less than a year
after ReNu with MoistureLoc went on the market, a connection was made between it and Fusarium keratitis.
November 2005—Hong Kong health officials tell Bausch & Lomb about more contact lens wearers being hospitalized due to severe and debilitating Fusarium keratitis symptoms.
February 20, 2006—After 29 cases of Fusarium keratitis are found in Hong Kong, Singapore and Malaysia since November 2005, Bausch & Lomb suspends sales of ReNu there.
March 3, 2006—Dr. David Chu in New Jersey tells Bausch & Lomb about three cases of Fusarium keratitis since December. When company fails to notify CDC within five days, Dr. Chu does. U.S. investigation commences.
March 22, 2006—FDA begins intensive inspection of Bausch & Lomb’s plant in Greenville, South Carolina.
April 10, 2006—Bausch & Lomb stops shipping ReNu with MoistureLoc to stores in U.S. but says they may continue to sell existing product until supplies run out.
April 13, 2006—Bausch & Lomb issues U.S. ReNu recall. Walgreens, WalMart and CVS don’t wait and have already removed ReNu with MoistureLoc from their shelves. AOA concurs with this action.
April 17, 2006—First personal injury ReNu lawsuits are filed in New York and Miami.
May 15, 2006—Bausch & Lomb issues worldwide ReNu recall.
August 23, 2006— Journal of the American Medical Association publishes results of CDC’s investigation. It demonstrates link between outbreak of Fusarium keratitis with use of ReNu with MoistureLoc.
October 2006—FDA issues 11-page warning letter to Bausch & Lomb, citing systemic violations of federal regulations at Greenville plant.
The information on this page pertains only to ReNu with MoistureLoc and not all ReNu products.
The Hissey Kientz Law Firm attorneys can handle lawsuits, claims and settlements in Alabama, Alaska, Arizona,
Arkansas, California, Colorado, Connecticut, D.C., Delaware, Florida, Georgia, Hawaii, Idaho, Illinois,
Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi,
Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota,
Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont,
Virginia, Washington, West Virginia,
Wisconsin and Wyoming. Our experienced lawyers can help.